These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 32459601)

  • 21. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
    Yildirim-Toruner C; Diamond B
    J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.
    Feinglass EJ; Arnett FC; Dorsch CA; Zizic TM; Stevens MB
    Medicine (Baltimore); 1976 Jul; 55(4):323-39. PubMed ID: 781466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus.
    Geng W; Zhang S; Cao J; Hong X; Duan Y; Jiang Y; Wei J
    Front Immunol; 2024; 15():1323209. PubMed ID: 38585267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions.
    Sim TM; Mak A; Tay SH
    Front Immunol; 2022; 13():957303. PubMed ID: 36016935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.
    Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus.
    Duarte-Delgado NP; Vásquez G; Ortiz-Reyes BL
    Autoimmun Rev; 2019 Apr; 18(4):426-432. PubMed ID: 30763633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-P antibodies and neuropsychiatric lupus erythematosus.
    Georgescu L; Mevorach D; Arnett FC; Reveille JD; Elkon KB
    Ann N Y Acad Sci; 1997 Aug; 823():263-9. PubMed ID: 9292053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuropsychiatric disorders in systemic lupus erythematosus: a general review (author's transl)].
    Verret JM
    Ann Med Interne (Paris); 1981; 132(3):205-14. PubMed ID: 7027867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment.
    Justiz-Vaillant AA; Gopaul D; Soodeen S; Arozarena-Fundora R; Barbosa OA; Unakal C; Thompson R; Pandit B; Umakanthan S; Akpaka PE
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
    Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
    Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal Atrophy in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.
    Liu S; Cheng Y; Zhao Y; Lai A; Lv Z; Xie Z; Upreti B; Wang X; Xu X; Luo C; Yu H; Shan B; Xu L; Xu J
    J Immunol Res; 2020; 2020():2943848. PubMed ID: 32626787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: A review.
    Liu Y; Tu Z; Zhang X; Du K; Xie Z; Lin Z
    Front Cell Dev Biol; 2022; 10():998328. PubMed ID: 36133921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
    Constantin A; Năstase D; Tulbă D; Bălănescu P; Băicuș C
    Lupus; 2020 Oct; 29(12):1509-1519. PubMed ID: 32757735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.
    Sato S; Temmoku J; Fujita Y; Yashiro-Furuya M; Matsuoka N; Asano T; Kobayashi H; Watanabe H; Migita K
    Fukushima J Med Sci; 2020 Apr; 66(1):1-9. PubMed ID: 32173681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
    Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
    EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus.
    Perricone C; Pendolino M; Olivieri M; Conti F; Valesini G; Alessandri C
    Isr Med Assoc J; 2015 Mar; 17(3):171-8. PubMed ID: 25946769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.